EF Georgescu, R Ionescu, M Niculescu, L … - World Journal of …, 2009 - pubmedcentral.nih.gov METHODS: All patients met the NCEP-ATP III criteria for metabolic syndrome. Histology confirmed
steatohepatitis, defined as a NAS greater than five up to 3 wk prior inclusion, using the current
criteria. Patients with viral hepatitis, chronic alcohol intake, drug abuse or other significant ... Cited by 3 - Related articles - All 11 versions
EF Georgescu - Advances in Therapy, 2008 - Springer Nonalcoholic fatty liver disease (NAFLD) is a condition pathogenically linked to metabolic syndrome
(MS) by insulin resistance (IR), and charac- terized by hepatic steatosis in the absence of significant
alcohol use, hepato- toxicity, and/or other known liver diseases. The principles of NAFLD ... Cited by 1 - Related articles - All 2 versions
DS De Silva, RM Wilson, C Hutchinson, … - American Journal of …, 2009 - Am Physiological Soc Aldosterone induces extracellular signal-regulated kinase (ERK)-dependent cardiac
remodeling. Fenofibrate improves cardiac remodeling in adult rat ventricular myocytes
(ARVM) partly via inhibition of aldosterone-induced ERK1/2 phosphorylation and ... Cited by 1 - Related articles - All 3 versions
MS Rosselli, AL Burgueño, J Carabelli, M Schuman, CJ … - Atherosclerosis, 2009 - Elsevier Rats were given a high-fat diet (HFD) for 8 weeks and after this period were randomly divided
into 3 groups. For 12 weeks along with the same access to HFD, one group (9 rats) received
losartan and another group received telmisartan (10 rats), both at 10 mg/kg ... Cited by 2 - Related articles - All 17 versions
Y Nabeshima, S Tazuma, K Kanno, H Hyogo, K … - Journal of Hepatology, 2009 - Elsevier A distinct subgroup of angiotensin II type 1 receptor (AT1R) blockers (ARBs) have been reported
to suppress the development of hepatic steatosis. These effects were generally explained by
selective peroxisome proliferator-activated receptor (PPAR)γ modulating properties of ... Related articles - All 26 versions
CV Rizos, MS Elisaf, EN Liberopoulos - Current Pharmaceutical …, 2009 - ingentaconnect.com Abstract: Hypertension is one of the major risk factors for cardiovascular disease. Angiotensin
receptor blockers (ARBs) are a class of antihypertensive drugs with established efficacy and
favorable safety profile. Telmisartan, a member of the ARB family, holds some additional ... Related articles - All 2 versions